BRANDON HUTCHISON: Open Payments
NPI 1821628405 · ASHLAND, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$235 in 14 payments from 9 companies in 2025. Trend: 2023 $237 · 2024 $278 · 2025 $235
Food & beverage: $235
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Novo Nordisk Inc | 3 | $45 |
| Dexcom, Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
Products named: Dexcom G6 Transmitter, FARXIGA, AIRSUPRA, Auvelity, TRELEGY ELLIPTA, Wegovy, Kerendia, REPATHA.
Industry payments across MS — which companies pay providers there.
